Ads
    Related paper
  1. DRUG DESIGNING FOR TARGETING FLT3 RECEPTOTTYROSINE KINASE FOR LEUKEMIA DISEASE
  2. Effect of Different Chemotherapy Regimens on the Development of Drug-Induced Liver Disease in Patients with Chronic Lymphocytic Leukemia
  3. NANO-DISPERSIONS (SUSPENSIONS): AN EMERGING TRENDIN ENHANCING DRUG SOLUBILITY AND DRUG TARGETING
  4. CHRONIC MYELOID LEUKEMIA STUDY FOR RESPONSE PATTERN WITH TYROSINE KINASE INHIBITORS
  5. Exploration of Anticancer Potential of Novel Pyrrolo[2,3-b]pyridine Derivatives Targeting V600E-BRAF Kinase: Molecular Docking, Pharmacokinetic and DFT Studies
  6. Glycogen Synthase Kinase-3β (GSK-3β) is a Critical Factor in Intracellular Signaling Pathways in Acute Lymphoblastic Leukemia
  7. Effect of Previous Use of Hydroxyurea on the Formation of Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia
  8. Tyrosine Kinase level and White Blood Cells Count in Untreated and Treated Chronic Myelogenous Leukemia Patients with BCR ABL gene
  9. Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: influence of coping strategies and psychological factors
  10. Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia